黄素在抑制三阴性乳腺癌中的作用
Shuai Wang1, Kuanyu Wang2, Cheng Li2
1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
Frontiers in pharmacology
|September 11, 2024
概括
来自传统中医药的黄胺在预防三阴性乳腺癌 (TNBC) 的生长和转移方面表现有前途. 它们通过准多种机制来工作,为TNBC患者提供潜在的新治疗途径.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 三重阴性乳腺癌 (TNBC) 由于转移和复发率高,因此具有重大临床挑战.
- 在TNBC中转移和复发与患者死亡率的增加密切相关.
- 目前晚期TNBC的治疗选择有限,需要新的治疗策略.
研究的目的:
- 审查黄类药物抑制TNBC的机制.
- 探索传统中医药中的黄类药物作为TNBC治疗干预的潜力.
- 巩固关于预防TNBC进展和转移的基于黄类药物的策略的知识.
主要方法:
- 关于黄类药物及其对TNBC的影响研究的文献综述.
- 分析包括诱导亡,细胞循环停止和抗血管生成在内的机制.
- 检查黄素对细胞外基质降解,有氧糖解和瘤微环境的影响.
主要成果:
- 黄类药物显示出针对TNBC的多目标和协调干预能力.
- 关键的抑制机制包括促进细胞亡和阻止细胞循环的进展.
- 黄素还调节细胞外基质,抑制血管生成和有氧糖解,并改善瘤微环境.
结论:
- 黄类化合物是TNBC的药理干预的一类有前途的化合物.
- 它们的多方面的作用为开发新型治疗方法来对抗TNBC转移和复发提供了坚实的基础.
- 对黄酸盐的进一步研究可能会改善晚期三阴性乳腺癌患者的治疗结果.
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


